In this interview, Dr. Jason Mouabbi speaks with Oncology Data Advisor about his research regarding the absence of lobular carcinoma in situ as a poor prognostic marker in invasive lobular carcinoma, which will be presented as a poster at the 2022 San Antonio Breast Cancer Symposium (SABCS).

Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ

Oncology Data Advisor®